Zoono (ASX:ZNO) share price slumps 16% on quarterly update

Despite some positive advancements, shareholders continued the selling pressure on Zoono shares today.

| More on:
A woman wearing glasses peers closely at something, ready to spray antimicrobial treatment.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Zoono Group Ltd (ASX: ZNO) share price slipped into the red in today's session. The dip arrives as Zoono announced its progress for the quarter.

Let's comb over the company's results and highlights in finer detail.

Quick refresher on Zoono

Zoono is a biotechnology company that specialises in environmentally-friendly antimicrobial products.

Its mission statement centres on providing non-toxic and sustainable germ protection to individuals across the globe.

Zoono has a market capitalisation of $108 million.

Zoono's quarterly results

The company has realised $28.8 million in cash receipts for the full year. This includes unaudited sales revenue of $6.6 million for the quarter.

Zoono also announced a suite of new sales and distribution agreements that are now in place. These include sales and distribution agreements in France, Russia, China and India.

For instance, Zoono is now selling to "several French multinational customers," and it has signed three new distribution agreements in China.

Furthermore, a new distributor in India placed a large 100,000-litre order, and "sales have been particularly strong in the public sector" in Russia.

Zoono exited the quarter with $7.4 million in cash and receivables. All positive signs for the Zoono share price.

Additional takeouts driving the Zoono share price

In addition to these agreements, Zoono announced a selection of "new business opportunities" in the report.

To illustrate, Zoono described advancements in "mould remediation" with a partner in South Africa. This activity aims to "prevent black mould growing on cardboard packaging".

Moreover, Zoono UK has started a strategic partnership with a third party in order to develop "a unique delivery system" for its Zoono Z-71 microbe shield.

The company is testing this system using "existing air conditioning infrastructure" in large buildings.

The proprietary process, which is owned by the third party, converts Zoono's solution into a gas.

As per the company, the gas "is then pumped throughout the building" via the air con. Because the "gasified Zoono is heavier than air, it settles on (and treats) the surface" it lands on.

Again on the the Z-71 shield, it displayed a "99.99% efficacy against [preventing] Coronavirus MHV-3 after 30 days" in trials conducted on the product in Brazil.

Despite these advancements, shareholders continued the selling pressure on Zoono shares today.

Zoono shares closed the day at 66 cents apiece, a 15.92% drop into the red from the market open.

Zoono share price snapshot

The Zoono share price has posted a year-to-date loss of nearly 50%, extending the previous 12 month's loss of 70%.

Both of these returns have lagged the S&P/ASX 200 Index (ASX: XJO) return of ~23% over the past year.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Happy shareholders clap and smile as they listen to a company earnings report.
Share Gainers

Why Brainchip, Cooper Energy, Core Lithium, and Neuren shares are roaring higher today

These shares are having a good time on hump day. But why?

Read more »

A little Asian girl is so excited by the bubbles coming out of her bubble machine.
Opinions

Worried about a frothy market? 2 ASX shares attractively priced AND 1 dead simple buy

Pricey markets don't require sitting on the sidelines.

Read more »

Three guys in shirts and ties give the thumbs down.
Share Fallers

Why Bellevue, Domain, Skycity, and Wildcat shares are tumbling today

These shares are having a tough time on hump day. But why?

Read more »

A man looks a little perplexed as he holds his hand to his head as if thinking about something as he stands in the aisle of a supermarket.
Opinions

This ASX 200 share is trading near 52-week lows. Is it time to buy?

Is this one of the most underrated stocks on the ASX right now?

Read more »

Broker looking at the share price.
Broker Notes

3 ASX All Ords shares just got BIG upgrades from top brokers

Leading brokers believe these ASX All Ords stocks could fly higher into 2025.

Read more »

A young well-dressed couple at a luxury resort celebrate successful life choices.
Opinions

Want to become wealthy? Invest in ASX shares for 2030 rather than 2025

Long-term investing in ASX shares make a lot of sense to me.

Read more »

A couple lying down and laughing, symbolising passive income.
Opinions

How to invest in ASX shares for big capital gains AND passive income

Certain types of ASX shares are capable of producing good returns, including dividends.

Read more »

Man sits smiling at a computer showing graphs
Share Market News

Broker tips this fast-growing ASX 200 tech stock to outperform

Goldman Sachs is very bullish on the outlook of this growing tech company.

Read more »